The prevalence and clinical significance of antibodies against b 2 -glycoprotein I (anti-b 2 GPI ) and antibodies against oxidized low-density lipoprotein (anti-ox-LDL) were evaluated as potential indicators of arterial disease in patients with systemic lupus erythematosus (SLE) and SLE with secondary antiphospholipid syndrome (APS). IgG anti-b 2 GPI and IgG anti-ox-LDL were measured by enzyme-linked immunosorbent assay (ELISA) in serum samples from 118 patients with SLE, including 40 with secondary APS. IgG anti-b 2 GPI were positive in 17% (20/118) of SLE patients. The presence and titres of IgG anti-b 2 GPI were strongly associated with a history of arterial thrombosis. Haemolytic anaemia was also significantly associated with the presence of IgG anti-b 2 GPI. The prevalence of IgG anti-ox-LDL was 53% (63/118), but there was no association with arterial thrombosis. No correlation between the values of anti-ox-LDL and those of anti-b 2 GPI was found. These results suggest that IgG anti-b 2 GPI could be a marker for arterial thrombosis in SLE patients, while IgG anti-ox-LDL were not associated with arterial disease in this group of lupus patients.
S lupus erythematosus (SLE) is an autoin the absence of cardiolipin if b 2 GPI was coated immune disorder in which atherosclerosis and arterial onto polystyrene enzyme-linked immunosorbent assay thrombosis contribute towards morbidity and mortal-( ELISA) plates where oxygen was introduced by irradiity [1] [2] [3] . It has been estimated that the risk of coronary ation. Therefore, the 'aPL family' is being recognized heart disease in SLE is 9-fold greater than that expected as a group of antibodies whose specificity is directed from a normal population [4] . not only towards phospholipids, but also towards A wide spectrum of mechanisms have been proposed phospholipid-binding proteins [6 ] . Furthermore, to account for arterial disease in patients with SLE.
Gharavi et al. [12] described the induction of aPL in As in the general population, smoking, hypertension, animal models by immunization with heterologous diabetes and a family history of vascular disease conb 2 GPI. b 2 GPI induces two distinct populations of tribute in some lupus patients. Additionally, the develautoantibodies: one directed against b 2 GPI and the opment of atherosclerotic manifestations in SLE has other with specificities for both phospholipid and been notably attributed to prolonged treatment with b 2 GPI. steroids and to their effect on the lipid profile [5] .
Oxidized low-density lipoprotein (ox-LDL) plays an Recently, interest has focused on autoimmuneimportant role in vascular events. Oxidation of LDL mediated pathways. Firstly, antiphospholipid antican occur in vivo and ox-LDL may enhance LDL bodies (aPL) play a major role in coagulation defects uptake by macrophage scavenger receptors, promoting and thrombosis. Initially, aPL were considered to be the transformation of macrophages into foam cells directed towards anionic phospholipids, but it was [13] . These events lead to chemotaxis of monocytes subsequently found that certain plasma proteins, and the production of endothelial cell adhesion molknown as 'phospholipid-binding proteins', act as cofacecules contributing to functional impairment of the tors [6 ] . The best characterized is b 2 -glycoprotein I vasomotor properties of involved arteries [14] [15] [16] [17] [18] . It ( b 2 GPI ). In 1990, three groups, Matsuura et al. [7] , has been shown that b 2 GPI decreases the uptake of Galli et al. [8] and McNeil et al. [9] , independently ox-LDL by macrophages [19] . Furthermore, it has reported that anticardiolipin antibodies (aCL) which been suggested that oxidation of LDL may induce a were associated with antiphospholipid syndrome conformational change in the b 2 GPI molecule recog-(APS) were not directed against cardiolipin alone, nized by aPL in SLE sera [20] . Ox-LDL is more because they did not bind to cardiolipin without a immunogenic than its native counterpart and induces plasma protein, b 2 GPI. Later, Matsuura et al.
[10] and the production of a heterogeneous population of Roubey et al. [11] reported that aCL bound to b 2 GPI specific anti-ox-LDL autoantibodies [21] . Anti-ox-LDL have been found in chronic periaortitis [22] , progressive carotid atherosclerosis [23] and SLE [24] .
a lipid-binding protein, apolipoprotein B [20] . It had containing 0.05% Tween 20 (PBS-Tween), 50 ml of serum samples diluted in PBS containing 1% bovine been suggested that anti-ox-LDL might be directed against b 2 GPI, which in turn obtains increased antiserum albumin (BSA) (Sigma Chemical Co., St Louis, MO, USA) were added in duplicate and incubated for genicity by binding to ox-LDL [24] . Matsuda et al.
[25], however, recently suggested that anti-ox-LDL is 1 h at room temperature, followed by 50 ml/well of a 1:2000 dilution of alkaline phosphatase-conjugated an antibody to ox-LDL itself, and it is not an antibody to cryptic or neoantigenic b 2 GPI. goat anti-human IgG (Sigma). One hundred microlitres per well of 1 mg/ml p-nitrophenylphosphate disodium Antibodies against b 2 GPI have been found in patients with SLE and APS, and are associated with (Sigma) in 1  diethanolamine buffer (pH 9.8) were added. Optical density was measured at 405 nm (OD thrombosis [26] [27] [28] [29] [30] [31] . Recently, we have demonstrated that anti-b 2 GPI, using human b 2 GPI as an antigen in 405) by a Titertek Multiskan MC apparatus ( Flow Laboratories, Herts.). The anti-b 2 GPI titre of each the absence of cardiolipin on irradiated plates, is a more specific marker for the APS than aCL detected sample was derived from the standard curve according to the dilutions of the positive control. by the conventional aCL assay [32] . We have also shown that the titres of anti-ox-LDL in APS patients with arterial thrombosis are higher than those without Anti-ox-LDL ELISA Antibodies against ox-LDL were detected as previsuch events [33] . In this study, we have investigated the prevalence of those antibodies in patients with SLE ously reported [33] . Native LDL was isolated by sequential ultracentrifugation from pooled plasma of and SLE with secondary APS, and their correlation with arterial diseases.
healthy fasting adults and dialysed for 30 h against PBS. Malondialdehyde (MDA) was freshly generated PATIENTS AND METHODS from malonaldehyde bis dimethylacetal by acid hydrolysis as described by Palinsky et al. [36 ] . MDA-LDL Patients A total of 118 patients attending the Lupus Clinic was prepared by incubating LDL with MDA and, after conjugation, MDA-LDL was dialysed extensively at St Thomas' Hospital were included in this study [114 females and four males; mean age 40 yr (range against PBS. For the ELISA, half of a microtitre plate (Immulon 10-71)]. The average follow-up was 10.9 yr (range 1-41). All patients fulfilled the revised ARA criteria 4) (Dynatech Laboratories Inc., Virginia, USA) was coated with LDL and the other half with MDA-LDL, for the classification of SLE [34] . Of the 118, 40 patients were diagnosed as having secondary APS both at 5 mg/ml in PBS containing 2 m ethylenediaminetetraacetic acid tetrasodium salt ( EDTA) and according to the proposed criteria [35] . Patients' records were carefully reviewed, including the presence 20 m butylated hydroxytoluene (Sigma), incubated at 37°C for 2 h and then overnight at 4°C. After washing of risk factors for arterial disease. Hypercholesterolaemia was defined as a total plasma cholesterol level four times with PBS-Tween, wells were blocked with 150 ml of 0.5% gelatine for 1 h at 37°C and washed >5 mmol/l. A history of hypertension was considered when the patient was under antihypertensive therapy again. Fifty microlitres per well of serum samples diluted 1:100 in PBS-Tween containing 1% BSA were or had in the supine position a diastolic blood pressure of >90 mmHg or a systolic blood pressure of added in duplicate and incubated for 2 h at room temperature. Plates were washed and alkaline phos->160 mmHg on three measurements in the hospital. Most of the patients included in our study (109/118, phatase-conjugated goat anti-human IgG (Sigma) in the sample diluent was added for 1 h at room tempera-92%) had been on steroids for an average of 6.3 yr. A patient was considered to be on a high dosage of ture. After the addition of substrate, the colour was read at a wavelength of 405 nm. Results were expressed steroids when receiving >20 mg/day of prednisolone or equivalent any time. Diagnostic techniques for as OD values, and binding to ox-LDL was calculated by subtracting the binding of antibody to native LDL arterial thrombosis included magnetic resonance imaging (MRI ) and/or computed tomography (CT ) from that to MDA-LDL. scans of the head, biochemistry, electrocardiogram, myocardial perfusion scans, coronary angiography, Statistical analysis All statistical analysis was performed by Statview II renal scintigraphy and Doppler ultrasound scanning and venography in cases of venous thrombosis. One (Apple Macintosh software). Categorical analysis was by x2 test and comparisons between two groups were hundred and four sex-and age-matched healthy controls were also included.
determined by the Mann-Whitney non-parametric test.
RESULTS

Anti-b 2
GPI ELISA Anti-b 2 GPI were measured as previously described Clinical features Thirty-three patients (28%) had a history of arter- [32] . Briefly, irradiated microtitre plates, Type C (Sumilon Bakelite, Tokyo, Japan) were coated with ial thrombosis, symptomatic cerebrovascular disease being the most frequent finding ( Table I ) . Twenty-50 ml of 4 mg/ml of purified human b 2 GPI in phosphatebuffered saline (PBS ) and incubated overnight at 4°C.
seven of the patients among those with arterial thrombosis (82%) were diagnosed as having secondary APS. After washing with PBS, plates were blocked with 3% gelatine for 1 h at 37°C. After three washes with PBS Twenty-eight patients (24%) developed venous throm- (x2 = 3.40, P = n.s.; x2 = 3.56, P = n.s.). Titres of IgG Peripheral occlusion of lower 2 (6) 1 1 aCL were not different between patients with and withlimb arteries out this feature (Mann-Whitney, P = n.s.). However, the titres of IgM aCL were significantly higher in the SLE, systemic lupus erythematosus; APS, antiphospholipid group of patients with haemolytic anaemia than in the syndrome.
*Some patients had recurrent thrombotic events.
group of patients without this feature (Mann-Whitney, P = 0.01). A history of haemolytic anaemia correlated with anti-b 2 GPI, and anti-dsDNA with the presence of bosis, and 35 of the 111 women with available obstetric data (31%) had pregnancy loss, although only 15%
anti-ox-LDL. No correlation was found between the titres of anti-ox-LDL and those of anti-b 2 GPI (data (17/111) had two or more losses.
Fifty-nine per cent of our patients had at least one not shown). risk factor for arterial thrombosis. Hypercholesterol-DISCUSSION aemia was recorded in 19% (22/114) of our SLE patients, 32% (34/105) smoked regularly and 28% (33/118) had a
The present study shows that IgG anti-b 2 GPI are associated with a history of arterial thrombosis. history of hypertension. Only one patient had diabetes mellitus defined by American Diabetes Association criDespite a high prevalence of anti-ox-LDL, we could not find any association between the presence of these teria [37] . However, when analysed independently, only hypertension was significantly associated with arterial antibodies and arterial thrombosis. SLE is an autoimmune disorder with a wide range thrombosis (15/33, 45% vs 21%, 18/85; x2 = 5.8, P < 0.01) while there were no differences in the presence of clinical and laboratory manifestations, and arterial disease is an important complication. Patients with of hypercholesterolaemia or smoking habit between both groups. A total of 58% of the patients (62/106) who SLE have many risk factors for arterial disease, including hypertension and abnormalities in the lipid profile. received corticosteroids were on high dosage during the follow-up. No association was found between a history
In our population, only hypertension was associated with arterial thrombosis, while a history of treatment of steroid treatment and the presence of arterial thrombosis [x2 = 2.34, P = not significant (n.s.)]. No with a high dosage of steroids did not seem to play a role in acute events. Several studies have shown that association was found with high dosages of steroids (x2 = 0.003, P = n.s.).
over one-third of SLE patients had a positive aCL titre [38, 39] , but only high titres of aCL are specific for the diagnosis of the APS. It has been reported that
Serological results
IgG anti-b 2 GPI were found in 17% (20/118) of our anti-b 2 GPI represent a more specific marker for the clinical features of the APS than aCL detected by the patients, 18 of them (90%) diagnosed as secondary APS, but in only 2% (2/104) of healthy controls (x2 = 12.34, standard assay [26] [27] [28] [29] [30] [31] [32] . In fact, anti-b 2 GPI might be able to suppress the natural anticoagulant function of P < 0.01). The titre of anti-b 2 GPI correlated strongly with that of aCL (correlation coefficient r = 0.781, b 2 GPI, facilitating thrombotic episodes. APS, unlike other thrombophilia states, is associated not only with P = 0.0001). In the group of patients with IgG antib 2 GPI, a history of arterial thrombosis was found more venous thrombosis, but also with arterial complications. Thus, it has been suggested that additional frequently than in anti-b 2 GPI-negative patients (14/20, 70% vs 19%, 19/98; x2 = 21.1, P < 0.01). Titres of IgG factors could be involved in the pathophysiology of arterial thrombosis in APS, over and above this proanti-b 2 GPI were significantly higher in patients with a history of arterial thrombosis than in those without coagulant state. It has been shown that in the presence of anti-b 2 GPI, ox-LDL uptake by macrophages is (Fig. 1) . On the other hand, IgG anti-ox-LDL were found in 53% (63/118) of SLE patients, but in 6% markedly increased [19] . This indicates that anti-b 2 GPI may favour the atherogenic process [19] and sub-(6/104) of healthy controls (x2 = 56.3, P < 0.01). There was no association between the presence of anti-ox-LDL sequent arterial thrombosis. In this study, we found a strong association between the presence and titres of and a history of arterial thrombosis, and the titres of these antibodies were not different between patients with anti-b 2 GPI and a history of arterial thrombosis in SLE patients. Although there are many mechanisms impliand without this complication (Fig. 2) . The association of other clinical manifestations with anti-b 2 GPI and cated in the development of arterial complications in SLE, our data suggest that secondary APS could anti-ox-LDL is shown in Table II . These data were analysed further by comparing SLE patients with and represent an important cause of arterial thrombosis in SLE. On the other hand, 53% of our patients were without secondary APS. Only anti-b 2 GPI were more frequent in the group of patients with secondary APS positive for anti-ox-LDL. This high prevalence in SLE has been reported by others [24] . We could not find aPL might induce erythrocyte destruction, possibly by direct binding and complement-mediated damage or any association between the presence of these antibodies and AT, which is also consistent with the Finnish by receptor-mediated entrapment by the reticuloendothelial system. Previous studies have suggested an population [24] . Long-term and prospective studies are necessary to evaluate whether anti-ox-LDL might association of IgM aCL with haemolytic anaemia [40] [41] [42] . In our series, we confirmed this finding. have a clinical significance in the pathogenesis of the arterial complications in SLE.
Whether haemolytic anaemia associates with antib 2 GPI or relates primarily with aCL remains unknown. In this study, anti-b 2 GPI were associated with a history of haemolytic anaemia. Some authors have aPL might recognize phospholipids in the erythrocyte membrane together or in close association with memsuggested that autoimmune haemolytic anaemia should be considered as a manifestation of APS in SLE since brane proteins [43] . 
